Livzon Pharmaceutical Group Inc.
LVZPF News Today: Stay Updated with the Latest Livzon Pharmaceutical Group Inc. News in Real Time
Find LVZPF news now at Meyka AI. Stay informed with the latest Livzon Pharmaceutical Group Inc. stocks updates, including price news, market analysis, and expert insights.

6740.T stock +30.65% pre-market 27 Mar 2026: Japan Display (JPX) volume surge
Pre-market update on 6740.T stock: Japan Display jumps to JPY 81.00 on heavy volume in JPX trading

0503.HK Lansen Pharma HKSE +40.94% pre-market 27 Mar 2026: outlook
Pre-market high-volume mover: 0503.HK stock jumps to HKD 1.79 on heavy volume; short-term outlook and Meyka AI forecast

BLK Stock Today, March 26: Asset-Manager Weakness Flags AUM Risk
BlackRock stock slips as AUM growth slows. We explain todayβs move, iShares ETF flows, valuation, and what German investors should watch into April earnings.

March 27: Flu Vaccine 2026 β CDC VE Data and Australia Free Shot Push
Flu vaccine 2026: CDC VE shows 24β36% fewer medical visits and 31% fewer hospitalizations. Australia Immunisation Coalition backs free influenza vaccination days. AU planning insights.

ADX.CN Advantex Marketing Inc CNQ drops 50% on 26 Mar 2026: liquidity risk
ADX.CN stock drops 50% to C$0.005 on 26 Mar 2026; valuation, liquidity and a C$0.01 forecast explained

Pre-market volume spike: Booktopia (BKG.AX) A$0.045 Mar 2026 β monitor catalyst
Pre-market volume spike in BKG.AX stock: Booktopia at A$0.045 with 28,414 shares; analysis and Meyka AI forecast

XG March 27: Producer SIMON Resigns; Avex Cuts Ties, Tour Continues
XG SIMON resignation: Junho Sakai apologizes after bail; Avex contract termination confirmed as tour continues. What this means for risk, revenue, and XG tour dates in Japan.

P36.SI Pan Hong Holdings (SES) down 11.67% 26 Mar 2026: watch SGD 0.05 support
P36.SI stock fell to **S$0.053** on 26 Mar 2026; quick analysis, Meyka AI grade and SGD 0.05 forecast

LN.TO stock C$1.38 intraday on TSX: earnings due 31 Mar 2026, watch catalyst
LN.TO stock earnings preview for 26 Mar 2026 β C$1.38 price, EPS -0.04, Meyka forecast +46.87% yearly upside